Journal
JOURNAL OF PINEAL RESEARCH
Volume 47, Issue 4, Pages 339-344Publisher
WILEY
DOI: 10.1111/j.1600-079X.2009.00720.x
Keywords
diabetes; glycogen; glycogen synthase kinase 3 beta; high fat diet; insulin resistance; melatonin; protein kinase C zeta
Categories
Funding
- Chi-Mei Medical Center, Yong Kang City, Taiwan
Ask authors/readers for more resources
Low levels of melatonin in circulation had been reported to be related to the development of diabetes. Melatonin administration in animals increases hepatic glycogen content to lower blood glucose. However, the signaling pathway for these effects is still unclear. The present study shows that intraperitoneal injection of 10 mg/kg melatonin ameliorated glucose utilization and insulin sensitivity in high fat diet-induced diabetic mice with an increase in hepatic glycogen and improvement in liver steatosis. We used HepG2 cells to investigate the signaling pathways for the melatonin-stimulated hepatic glycogen increment. Treatment of HepG2 cells with 1 nm melatonin markedly increased glycogen synthesis which was blocked by the melatonin receptor antagonist luzindole. In addition, melatonin increased the phosphorylation of subcellular signals at the level of protein kinase C zeta (PKC zeta), Akt, and glycogen synthase kinase 3 beta (GSK3 beta) while the increase in glycogen synthesis induced by melatonin was inhibited by PKC zeta pseudopeptide. However, 3', 5'-cyclic adenosine monophosphate-activated protein kinase (AMPK) was not influenced by melatonin treatment. Taken together, melatonin improves glucose intolerance and insulin resistance in high fat diet-induced diabetic mice and stimulates glycogen synthesis via a PKC zeta-Akt-GSK3 beta pathway in HepG2 cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available